Skip to main content

Dave Muoio

By Dave Muoio | 03:06 pm | July 31, 2020
Also: DarioHealth announced $28.6 million private placement transaction; StuffThatWorks launches with $9 million seed funding.
By Dave Muoio | 03:49 pm | July 30, 2020
Virtual primary care customers living in specific regions will have the option to use Alto's app and services at no additional cost.
By Dave Muoio | 02:29 pm | July 30, 2020
Although the company's rapid growth has been fueled by COVID-19, new contracts and state-by-state trends have CEO Jason Gorevic confident that telehealth adoption is here to stay.
By Dave Muoio | 03:52 pm | July 29, 2020
The roughly three-year-old company says it now has a post-money valuation over $1 billion.
By Dave Muoio | 01:14 pm | July 29, 2020
A new study conducted by the digital chronic disease management company highlighted engagement behaviors associated with stronger outcomes over 12 months.
By Dave Muoio | 09:38 am | July 29, 2020
The strategic investment will help Heal expand its services into Chicago, Charlotte, Houston and other new regions.
By Dave Muoio | 12:41 pm | July 28, 2020
The company said that it has raised $110 million since November of 2019.
By Dave Muoio | 04:00 am | July 28, 2020
The 12-year-old French company is best known for its connected consumer health devices.
By Dave Muoio | 03:15 pm | July 27, 2020
The FDA now allows LabCorp's platform to test patients with no COVID-19 symptoms, or to run samples from up to five patients at a time.
By Dave Muoio | 03:56 pm | July 24, 2020
The Patient Controller app works with Abbott's Infinity DBS System, Proclaim XR SCS System and Proclaim DRG Neurostimulation System.